From: Testing mapping algorithms of the cancer-specific EORTC QLQ-C30 onto EQ-5D in malignant mesothelioma
Dimension | Mean (SD) | Dataset range (Dimension range) |
---|---|---|
EQ-5D Utility UK Tariff | 0.657 (0.253) | −0.135-1.0 (−0.594-1.0) |
EQ-5D Utility US Tariff | 0.743 (0.174) | 0.145-1.0 (−0.109-1.0) |
EQ-5D Utility Dutch Tariff | 0.711 (0.223) | −0.050-1.0 (−0.329-1.0) |
EQ-5D Utility Korean Tariff | 0.735 (0.159) | 0.100-1.0 (−0.171-1.0) |
EORTC QLQ C-30 | Â | Â |
Global Health Status | 56.3 (23.3) | 0-100 (0–100) |
Physical Functioning | 65.4 (23.2) | 0-100 (0–100) |
Role Functioning | 54.5 (31.3) | 0-100 (0–100) |
Emotional Functioning | 79.3 (23.8) | 0-100 (0–100) |
Cognitive Functioning | 76.4 (25.8) | 0-100 (0–100) |
Social Function | 63.4 (32.5) | 0-100 (0–100) |
Fatigue | 45.9 (26.6) | 0-100 (0–100) |
Nausea/Vomiting | 12.5 (18.3) | 0-100 (0–100) |
Pain | 27.4 (27.4) | 0-100 (0–100) |
Dyspnoea | 43.7 (28.0) | 0-100 (0–100) |
Insomnia | 30.7 (32.9) | 0-100 (0–100) |
Appetite | 28.4 (31.3) | 0-100 (0–100) |
Constipation | 21.6 (29.0) | 0-100 (0–100) |
Diarrhoea | 7.4 (18.8) | 0-100 (0–100) |
Financial Problems | 10.1 (22.1) | 0-100 (0–100) |